全文获取类型
收费全文 | 9434篇 |
免费 | 727篇 |
国内免费 | 143篇 |
专业分类
耳鼻咽喉 | 126篇 |
儿科学 | 115篇 |
妇产科学 | 134篇 |
基础医学 | 1634篇 |
口腔科学 | 91篇 |
临床医学 | 741篇 |
内科学 | 1938篇 |
皮肤病学 | 471篇 |
神经病学 | 547篇 |
特种医学 | 643篇 |
外科学 | 1157篇 |
综合类 | 31篇 |
一般理论 | 3篇 |
预防医学 | 312篇 |
眼科学 | 204篇 |
药学 | 1083篇 |
中国医学 | 177篇 |
肿瘤学 | 897篇 |
出版年
2023年 | 71篇 |
2022年 | 48篇 |
2021年 | 376篇 |
2020年 | 251篇 |
2019年 | 335篇 |
2018年 | 336篇 |
2017年 | 316篇 |
2016年 | 470篇 |
2015年 | 624篇 |
2014年 | 694篇 |
2013年 | 767篇 |
2012年 | 1008篇 |
2011年 | 954篇 |
2010年 | 590篇 |
2009年 | 500篇 |
2008年 | 547篇 |
2007年 | 534篇 |
2006年 | 434篇 |
2005年 | 380篇 |
2004年 | 300篇 |
2003年 | 250篇 |
2002年 | 233篇 |
2001年 | 30篇 |
2000年 | 32篇 |
1999年 | 29篇 |
1998年 | 22篇 |
1997年 | 17篇 |
1996年 | 12篇 |
1995年 | 18篇 |
1994年 | 7篇 |
1993年 | 11篇 |
1992年 | 13篇 |
1991年 | 13篇 |
1990年 | 13篇 |
1989年 | 8篇 |
1988年 | 10篇 |
1987年 | 6篇 |
1986年 | 4篇 |
1985年 | 6篇 |
1984年 | 8篇 |
1983年 | 5篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1973年 | 2篇 |
1972年 | 2篇 |
1971年 | 3篇 |
1966年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
Esophagus - Pulmonary complications are common after esophageal cancer surgery, but information regarding fatal respiratory events, such as postoperative acute respiratory distress syndrome (ARDS)... 相似文献
2.
3.
Dong Kyu Kim Joon Ho Kwon Heung Kyu Ko Junhyung Lee Kichang Han Gyoung Min Kim Man-Deuk Kim Jong Yun Won Hyun-Chel Joo Young-Guk Ko Do Yun Lee 《Journal of vascular and interventional radiology : JVIR》2021,32(1):39-48
PurposeTo evaluate the feasibility, safety, and effectiveness of N-butyl cyanoacrylate (NBCA) embolization for the treatment of aortic dissection.Materials and MethodsIn this single-center retrospective study conducted from February 2003 to June 2019, NBCA embolization of an aortic false lumen was attempted in 12 patients (median age, 59 y; range, 41–68 y) and thoracic endovascular aortic repair (TEVAR) was performed in 53 patients (median age, 59 y; range, 37–70 y) for aortic dissection with one or more indications of persisting pain, malperfusion, rupture or impending rupture, maximal aortic diameter ≥ 55 mm, and/or rapid aortic enlargement. The main exclusion criterion for embolization was the presence of fast blood flow in the aortic false lumen on aortography. The efficacy of NBCA embolization and TEVAR was compared by evaluating technical and clinical outcomes, repeat intervention–free survival (RFS), and overall survival (OS).ResultsTechnical success was achieved in 11 of the 12 patients treated with NBCA embolization (91.7%), and clinical success was achieved in 9 of these 11 (81.8%). No significant difference was found between embolization and TEVAR in clinical success rates (embolization, 81.8%; TEVAR, 84.9%; P = .409) or procedure-related complications (embolization, 1 patient [8.3%]; TEVAR, 4 patients [7.5%]; P = .701). In addition, embolization showed comparable 5-y RFS (embolization, 82.5% ± 9.3; TEVAR, 85.5% ± 4.8; P = .641) and 5-y OS (embolization, 100%; TEVAR, 95.4% ± 3.2; P = .744) rates to TEVAR.ConclusionsNBCA embolization of the false lumen in aortic dissection seems to be a safe and effective treatment modality for the closure of false lumen in selected patients. 相似文献
4.
5.
Kyung-Min Lee Eun Hye Hwang Seong Eun Kang Cheng Hyun Lee Hyebin Lee Hyeon Jeong Oh Kwangsoo Kim Jiwon Koh Han Suk Ryu 《JOURNAL OF BREAST CANCER》2020,23(6):599
PurposeA relatively low response to chemotherapy has been reported for hormone receptor (HR)-positive breast cancer. In this study, we investigated the role of tryptophanyl-transfer RNA synthetase (WARS) in the chemotherapeutic response of HR-positive breast cancer.MethodsPre-chemotherapeutic needle biopsy samples of 45 HR-positive breast cancer patients undergoing the same chemotherapeutic regimen were subjected to immunohistochemistry. To investigate the biological functions of WARS in HR-positive breast cancer, we conducted cell viability assay, flow cytometry analysis, caspase activity assay, Quantitative real-time polymerase chain reaction, and western blotting using WARS gene-modulated HR-positive breast cancer cells (T47D, ZR-75-1, and MCF7).ResultsWARS overexpression in HR-positive breast cancer patients showed a significant correlation with favorable chemotherapy response. Downregulation of WARS increased cell viability following docetaxel treatment in tumor cell lines. On the other hand, WARS overexpression sensitized the therapeutic response to docetaxel. Additionally, downregulation of WARS caused a decrease in the number of apoptotic cell populations by docetaxel. Poly (ADP-ribose) polymerase cleavage and caspase 3/7 activity were increased in docetaxel-treated tumor cells with WARS overexpression.ConclusionOur results suggest that WARS might be a potential predictor for chemotherapy response in patients with HR-positive breast cancer as well as a novel molecular target to improve chemosensitivity. 相似文献
6.
Min Hee Hong MD Seong Gu Heo PhD Yun-Gyoo Lee MD PhD Hyo Song Kim MD PhD Keon Uk Park MD PhD Hoon-Gu Kim MD PhD Yoon Ho Ko MD PhD Ik-Joo Chung MD PhD Young Joo Min MD PhD Min Kyoung Kim MD PhD Kyu Ryung Kim PhD Jinseon Yoo MS Tae-Min Kim MD PhD Hye Ryun Kim MD PhD Byoung Chul Cho MD PhD 《Cancer》2020,126(20):4521-4531
7.
8.
Soojung Hong Ju Hyun Lee Eun Kyeong Chun Kwang-Il Kim Jin Won Kim Se Hyun Kim Yun-Gyoo Lee In Gyu Hwang Jin Young Kim Su-Jin Koh Yoon Ho Ko Seong Hoon Shin In Sook Woo Tae-Yong Kim Ji Yeon Baek Hyun Jung Kim Hyo Jung Kim Myung Ah Lee Jung Hye Kwon Yong Sang Hong Hun-Mo Ryoo Jee Hyun Kim 《The oncologist》2020,25(3):e502-e511
9.